Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02233595 · ClinicalTrials.gov registry record
Evaluation of Rectal Cancer Treatment Response Using PET/MRI
A clinical trial, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- 7
- Enrollment target
NCT02233595 is a clinical trial that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 7 participants.
The verdict
NCT02233595 was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- 7 participants
- Enrollment target
Study Summary
The investigators will be using the combination of FDG-PET and multiparametric MRI in pre- and post-adjuvant chemoradiation therapy in order to attempt to predict pathologic response on surgical resection.
Interventions
- RADIATION Chemoradiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2014-10-15 |
| Est. Completion | 2018-01-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02233595
The ClinicalTrials.gov registry entry for NCT02233595 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Chemoradiation is the first listed.
NCT02233595 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02233595 about?
NCT02233595 is a clinical study titled "Evaluation of Rectal Cancer Treatment Response Using PET/MRI". The investigators will be using the combination of FDG-PET and multiparametric MRI in pre- and post-adjuvant chemoradiation therapy in order to attempt to predict pathologic response on surgical resection.
What is the current status of trial NCT02233595?
This trial is currently terminated. The enrollment target is 7 participants. The study started on 2014-10-15. Estimated completion is 2018-01-28.
What interventions are being tested in trial NCT02233595?
The interventions under investigation include: Chemoradiation (RADIATION).
Who is sponsoring clinical trial NCT02233595?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.